Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P50583 (
asymmetrical
)
12,197
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
A group of cycloalkyl and aryl ester analogues of nifedipine (
CAS
21829-25-4), in which the ortho-nitrophenyl group at position 4 is replaced by a 2-phenyl-4(5)-imidazolyl substituent, were synthesized and evaluated as calcium channel antagonist using the high K+ contraction of guinea-pig ileal smooth muscle. The results for the symmetrical esters in cycloalkyl and aryl esters showed that increasing the length of the methylene chain in C3 and C5 ester substituents (from n = 0 to n = 3) increased activity. A comparison of the effect of cyclohexyl relative to phenyl substituent showed that cyclohexyl derivatives were more active than phenyl derivatives. In contrast to symmetrical derivatives, comparison of the activities of
asymmetrical
esters showed that phenyl derivatives were more active than cycloalkyl derivatives. The results demonstrate that compounds 5a, 8a, 8l and 8n had similar activity to and compounds 5b, 5c, 5d and 5i were more active than the reference drug nifedipine. The structure-activity data indicate that the 4-(2-phenyl-4(5)-imidazolyl) moiety is a bioisoester of the o-nitro group of nifedipine.
...
PMID:Synthesis and calcium channel antagonist activity of new 1,4-dihydropyridine derivatives containing lipophilic 4-imidazolyl substituents. 1550 Jan 95
Seed oils from new recombinant high-stearic sunflower lines (Helianthus annuus L.) have been characterized. These new lines were generated by crossing high stearic acid lines between themselves or by crossing them with standard and high-oleic sunflower lines. Of the novel lines generated, the lines
CAS
-29 and
CAS
-30 are on a standard background and contain up to 34.5% of stearic acid. In contrast,
CAS
-15 and
CAS
-33 are on a high oleic acid background and contain only 24.9 and 17.4% of stearic acid, respectively. The stearic acid contents of lines
CAS
-19 and
CAS
-20 are 10.0 and 21.5%, respectively, and they have only one of the two genes that control the high stearic acid trait. In accordance with their vegetable origin, these lines have a low percentage of stearic acid in the sn-2 position of the TAGs, from 0.6 to 2.1%. The amount of disaturated TAGs increases with the stearic acid content, from 1.8% in the standard line to between 5.1% in
CAS
-20 and 38.5% in
CAS
-29. There was also a concomitant reduction in triunsaturated TAGs, which were reduced to levels as low as 8.4% in
CAS
-29, as opposed to the 67.9% that they constitute in the standard line RHA-274. The
asymmetrical
distribution of the saturated fatty acids between the sn-1 and sn-3 TAG positions ranges from 0.26 to 0.36, being lower in those lines with higher oleic acid content.
...
PMID:Oils from improved high stearic acid sunflower seeds. 1596 13